▾

External sources (not reviewed)

Substances in the amphetaminegroup are the second most commonly used drugs, followed by cocaine and opiates.

[...] effects (e.g. methamidophos andtriazophos, [...][...]

The following reports of working groups were made available at intersessional meetings of the Commission: (a) the report of the meeting of the working group on supply reduction, held in Vienna from 23 to 25 June 2008 (UNODC/CND/2008/WG.1/3); (b) the report of the meeting of the working group on countering money-laundering and promoting judicial cooperation, held in Vienna on 30 June and 1 July 2008 (UNODC/CND/2008/WG.2/3); (c) the report of the meeting of the working group on international cooperation on the eradication of illicit drug crops and on alternative development, held in Vienna from 2 to 4 July 2008 (UNODC/CND/2008/WG.2/3); (d) the report of the meeting of the working group on drug demand reduction, held in Vienna from 15 to 17 September 2008 (UNODC/CND/2008/WG.2/3); and (e) the report of the meeting of the working group on control of precursors and of amphetamine-type stimulants, held in Vienna from 17 to 19 September 2008 (UNODC/CND/2008/WG.2/3).

The JECFA Secretariat recalled that in its exposure assessment for ractopamineresidues JECFA had taken a very conservative approach that also takes kidney and liver into account, and that if other tissues would be consumed, such as lung or intestines, they would replace the tissues being considered in the food basket rather than be added.

The treatment demand related to use of amphetamine-type stimulants is relatively small, but it has considerably increased worldwide over the past decade, especially in South-East Asia, Oceania and North America.

Speakers also expressed concern at the increase in the use of amphetamine-type stimulants, cannabis and cocaine in Asia and Africa and at the increase in the use of drugs among youth and women.

Because of this, the data could not be used directly to re-evaluate ractopamine residue levels in pigs, but when assumptions are made to estimate free ractopamine levels, based on the ratio of free ractopamine to total residues, the data submitted by China could confirm the results from the residue studies that formed the basis for the proposed MRLs in pig tissues.

If you’re worried aboutacrylamide,avoid or cut back on fried or deep-fried foods that have been shown to contain it, such as French fries and potato chips.

The presence in urine of salbutamol in excess of 1000 ng/mL or formoterol in excess of 30 ng/mL is presumed not to be an intended therapeutic use of the substance and will be considered as an Adverse Analytical Finding unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of the use of the therapeutic inhaled dose up to the maximum indicated above.

[...] [...] additionof melamine to various [...]

Possession of Methamphetamine: A possession of methamphetamine arrest of a MW/42 was made at 5:01pm, at Encinita Avenue & Sereno Drive.

Underpinning all effective countermeasures was the need for law enforcement officers to be well informed, trained, adequately equipped and knowledgeable in the identification of amphetamine-type stimulants and their precursors.

A design of experiments was conducted by varying the levels of three surfactants (sodium lauryl ether sulfate, sodium lauryl sulfate, and cocamidopropyl betaine) in formulations containing cationic cassia polymers of different cationic charge density (1.7 and 3.0m Eq/g).

Increasing resistance of the malaria parasite to chloroquine and sulphadoxine-pyrimethamine —previously the most widely used antimalarial treatments — has prompted sixty-eight countries to change their national treatment protocols to incorporate the new and highly-effective artemisinin-based combination therapies or ACTs.

Polyureas oftenhave aminesonthe B (resin) side.

To order a valve withapolyimide stem tip, insert V into the valve ordering number.

The breakthrough of the new generation of eye allergy therapy, Olopatadine, lies in its unique functions: It inhibits the H1-receptor and stabilizes the human conjunctival mast cell at the same time.

The request for the reformulation of ipratropium was withdrawn since manufacturing of this MDI commenced only in 2004; and incremental operating costs were recalculated based on the 2003 CFC consumption of 6.1 ODP tonnes and not on the 2007 reported consumption of 7.4 ODP tonnes.

[...] [...] of tyrosine kinase, block enzyme [...]

Intermittent preventive treatment involves providing pregnant women with at least two doses of an anti-malarial drug, currently sulphadoxine-pyrimethamine (SP), at each scheduled antenatal visit after the first trimester, whether they show symptoms of infection with malaria or not.

The objectives of the project are: to eliminate the use of CFCs at Laboratorio Pablo Cassará for the production of salbutamol CFC-MDIs; to eliminate the use of CFCs at Laboratorio Denver Farma for the production of salbutamol and budesonide CFC-MDIs; to provide technical support for alternative formulations for four locally-owned laboratories filling their own MDIs through third parties; and to support the MDI transition strategy.

[...] [...] concentration of salbutamol(free plus glucuronide) greater than 1000 ng/mL will be considered an Adverse Analytical Finding unless the Athlete proves that the abnormal result was the consequence of the therapeutic use of inhaled salbutamol.

Ingredients: water (mangosteen infused water), glycerin (palm), acetyl glucosamine, niacinamide, tocopherol (soybean/corn/canola oil), mangosteen pericarp oil (BioActive pericarp oil), lactobacillus/mangosteen pericarp ferment filtrate (BioActive polymeric and acidic complex), garcinia mangostana pericarp powder (mangosteen), sucrose laurate (sugar cane), gluconolactone (corn), xanthan gum (kelp), acetyl carnitine hcl, sorbitol (corn), glucose, sucrose dilaurate (sugar cane), sodium hyaluronate, algae extract (microalgae), plantago lanceolata leaf extract (plantain), sucrose trilaurate [...][...]

[...] [...] days 1-21 of each 28-day cycle) plus low-dose dexamethasone (40 mg per day given only on Days 1, 8, 15 and 22 of each 28-day cycle for patients 75 years or younger, or 20 mg per day given only on Days 1, 8, 15 and 22 of each 28-day cycle for patients greater than 75 years of age) versus pomalidomide (4 mg once daily on days 1-21 of each 28-day cycle) alone in patients with relapsed multiple myeloma who were refractory to their last myeloma therapy and had receivedlenalidomide and bortezomib.